A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis: Substance Use and Misuse
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The psychiatric symptom profile of methamphetamine-associated psychosis (MAP) has varied considerably across studies of different research designs. We performed a systematic review to examine the available evidence for specific psychotic symptoms associated with MAP, including the clinical course and longitudinal changes in this symptom profile. METHODS: Five key electronic databases were searched to identify studies that examined the symptom profile or clinical course of MAP in individuals identified as having MAP. The reporting of specific psychiatric symptoms, and duration of symptoms where available, was recorded for each study. RESULTS: Ninety-four articles were identified (n = 7387), including case-control (k = 29), cross-sectional (k = 20), experimental (k = 6), case report (k = 29), and longitudinal (k = 20) studies. Persecutory delusions, auditory and visual auditory hallucinations were by far the most commonly reported symptoms (reported in 65-84% of studies). Hostility, conceptual disorganization, and depression were reported in a large proportion of studies (31-53%). Negative symptoms were mostly absent (<20%). The median percentage of participants with persistent psychotic symptoms (>1 month duration) across studies was 25% (excluding case reports). CONCLUSION: Persecutory delusions, auditory and visual hallucinations, hostility, depression and conceptual disorganization are central to MAP, whereas negative psychotic symptoms are typically absent. An overrepresentation of institutionalized or male participants may have overemphasized negative symptoms and underreported affective symptoms in past research. Symptoms of MAP may persist beyond one month after drug cessation in some individuals. Clinicians are encouraged to manage affective symptoms in MAP individuals, and monitor for the development of chronic psychotic symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513
Sex differences in anxiety and depression clinical perspectives
Altemus, M., Sarvaiya, N., & Neill Epperson, C. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.004 · Cited by 1,413
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review
Ochoa, S., Usall, J., Cobo, J., Labad, X., & Kulkarni, J. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/916198 · Cited by 735
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295 · cited 3×
“While psychotic symptoms induced by methamphetamine are typically transient and resolve within one month of acute intoxication (Bell, 1965; Chen et al., 2003), evidence indicates that a minority of chronic users experience a form of persistent MAP that may continue for several months or years (Chen…”
BackgroundMethamphetamine Psychosis: Epidemiology and Management
Glasner-Edwards, S., & Mooney, L. J. (2014) · CNS Drugs · doi:10.1007/s40263-014-0209-8 · Cited by 266
Hartley, S., Barrowclough, C., & Haddock, G. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12080 · Cited by 234
McKetin, R., Lubman, D. I., Baker, A. L., Dawe, S., & Ali, R. L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.283 · Cited by 221
Self-citationCooper, L., Peters, L., & Andrews, G. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00021-1 · Cited by 101
The many continua of psychosis
van Os, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1068 · Cited by 41
Cited by
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14688 · Cited by 202
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17
Jones, C. M., Underwood, N., & Compton, W. M. (2020) · Addiction · doi:10.1111/add.14812 · Cited by 142
Bell, V., Raihani, N., & Wilkinson, S. (2021) · Clinical Psychological Science · doi:10.1177/2167702620951553 · Cited by 78
“Increased dopamine turnover in the mesolimbic dopamine system is present in in patients with delusions (Winton-Brown et al., 2014) whereas increasing dopamine turnover by the use of stimulant drugs causes delusions after chronic use (Voce et al., 2019).”
BackgroundAdverse childhood experiences and stimulant use disorders among adults in the United States
Tang, S., Jones, C. M., Wisdom, A., Lin, H.-C., Bacon, S., & Houry, D. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113870 · Cited by 22
Metadata
- Authors
- Voce, A., Calabria, B., Burns, R., Castle, D., & McKetin, R.
- Venue
- Substance Use & Misuse
- Publisher
- Informa UK Limited
- Published
- 2019-01-29
- Volume
- 54
- Issue
- 4
- Pages
- 549-559
- ISSN
- 1082-6084 (ISSN-L)
- 1532-2491
- OpenAlex
- W2912254966
- Cited by
- 75
- References
- 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis: Substance Use and Misuse. https://app.cochat.ai/papers/10.1080/10826084.2018.1521430
- The paper
- Voce, A., Calabria, B., Burns, R., Castle, D., & McKetin, R. (2019). A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis: Substance Use and Misuse. Substance Use & Misuse. https://doi.org/10.1080/10826084.2018.1521430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.